Mice with PTEN-deficient myeloid cells exhibit decreased chemotherapy-induced NLRP3 activity in the tumour microenvironment and resistance to Mitoxantrone, suggesting that PTEN-induced NLRP3 activity promotes anti-tumour immunity and tumour suppression [32]. This evidence concerns the gene NLRP3 and neoplasm.